INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 303
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Fountain Life

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Live longer, live healthier.' LinkedIn ads: 'Live with clarity. Perform at your highest level.'

Audienceread

Affluent longevity-focused consumers wanting an all-inclusive diagnostics membership.

Pricing & termsverified

Membership prices not published on the reviewed page; secondary signal ~$19.5k+/yr (longevitybenchmark.com), unverified.

Clinical relationshipspartial

Health assessment, results review, healthspan optimization with in-person clinician days; 200+ markers plus MRI/CT per secondary source.

Pharmacy & fulfillmentpartial

Not applicable - diagnostics-led; prescribing scope not established.

Advertising snapshotpartial

Google: ~700 ads header (US, last 30 days, 20 Oct 2026) with cards from verified advertiser 'Fountain Life Holdings'. Meta: Meta Ad Library keyword lookup for 'fountainlife.com' displayed ~41 results on 20 Oct 2026. LinkedIn: LinkedIn Ad Library: 105 ads from Fountain Life on 20 Oct 2026.

Founding yearnot_found

Not established in this pass.

    Foundersnot_found

    Not established in this pass.

      Location & entity contextnot_found

      Not stated on pages reviewed.

        Search visibility samplenot_found

        Not assessed in this pass.

          THE MODERN DOSING WEEKLY

          The peptide news
          that changes your week.

          Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.